Next Article in Journal
Mediating Role of Emotional Intelligence in the Relationship between Anxiety Sensitivity and Academic Burnout in Adolescents
Next Article in Special Issue
COVID-Related Distress Is Associated with Increased Menstrual Pain and Symptoms in Adult Women
Previous Article in Journal
Others’ Facial Expressions Influence Individuals Making Choices and Processing Feedback: The Event-Related Potential and Behavioral Evidence
Previous Article in Special Issue
A Global Survey of Ethnic Indian Women Living with Polycystic Ovary Syndrome: Co-Morbidities, Concerns, Diagnosis Experiences, Quality of Life, and Use of Treatment Methods
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJERPH
Volume 20
Issue 1
10.3390/ijerph20010569
ijerph-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Factors Associated with the Prevalence and Severity of Menstrual-Related Symptoms: A Systematic Review and Meta-Analysis

by
Risa Mitsuhashi
1,
Akemi Sawai
2,
Kosuke Kiyohara
3,
Hitoshi Shiraki
4 and
Yoshio Nakata
4,*
1
Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8574, Japan
2
Research Institute of Physical Fitness, Japan Women’s College of Physical Education, 8-19-1 Kitakarasuyama, Setagaya-ku 157-8565, Japan
3
Department of Food Science, Faculty of Home Economics, Otsuma Women’s University, 12 Sanban-cho, Chiyoda-ku 102-8357, Japan
4
Faculty of Health and Sport Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8574, Japan
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2023, 20(1), 569; https://doi.org/10.3390/ijerph20010569
Submission received: 11 November 2022 / Revised: 24 December 2022 / Accepted: 26 December 2022 / Published: 29 December 2022
(This article belongs to the Special Issue Women's Health Care: Menstrual Disorders, Endometriosis and Chronic Pelvic Pain)
Browse Figures
Review Reports Versions Notes

Abstract

:
This study aimed to identify factors associated with the prevalence and severity of menstrual-related symptoms. The protocol was registered in PROSPERO (CRD42021208432). We conducted literature searches of PubMed and Ichushi-Web and used the Jonna Briggs Institute critical appraisal checklist to assess the quality. Of the 77 studies included in the meta-analysis, significant odds ratios (ORs) were obtained for eight factors associated with primary dysmenorrhea (PD): age ≥ 20 years (OR: 1.18; 95% confidence interval [CI]: 1.04–1.34), body mass index (BMI) < 18.5 kg/m2 (OR: 1.51; 95% CI: 1.01–2.26), longer menstrual periods (OR: 0.16; 95% CI: 0.04–0.28), irregular menstrual cycle (OR: 1.28; 95% CI: 1.13–1.45), family history of PD (OR: 3.80; 95% CI: 2.18–6.61), stress (OR: 1.88; 95% CI: 1.30–2.72), sleeping hours < 7 h (OR: 1.19; 95% CI: 1.04–1.35), and bedtime after 23:01 (OR: 1.30; 95% CI: 1.16–1.45). Two factors were associated with severity of PD (moderate vs. severe): BMI < 18.5 kg/m2 (OR: 1.89; 95% CI: 1.01–3.54) and smoking (OR: 1.94; 95% CI: 1.08–3.47). PD severity (mild vs. severe) and prevalence of premenstrual syndrome were associated with BMI < 18.5 kg/m2 (OR: 1.91; 95% CI: 1.04–3.50) and smoking (OR: 1.86; 95% CI: 1.31–2.66), respectively. The identified risk factors could be utilized to construct an appropriate strategy to improve menstrual symptoms and support women’s health.

1. Introduction

Menstruation is a physiological phenomenon that specifically occurs in women. In a healthy woman, it is regulated by cyclical fluctuations of female hormones such as estrogen and progesterone, which occur regularly during a cycle of about one month [1]. During the menstrual cycle, from the first day of menstruation to the day preceding the next menstrual period, various changes occur in a woman’s body caused by major hormonal fluctuations. Therefore, menstrual-related symptoms are one of the most common problems faced by women [1]. In particular, primary dysmenorrhea (PD) and premenstrual syndrome (PMS) are reported to cause symptoms in many women with considerable impact on their daily life [2,3,4]. Therefore, the improvement of menstrual-related symptoms should lead to better quality of life for a vast number of women. Many studies have investigated the factors associated with the prevalence and severity of menstruation-related symptoms [5,6]. Faramarzi et al. [5] reported that women with higher stress levels and higher caffeine intake exhibited a high rate of dysmenorrhea but revealed no association with physical activity or breakfast skipping. Hu et al. [6] reported that women with short sleep duration, late bedtime, and those who skipped breakfast had a high rate of dysmenorrhea, but physical activity and caffeine intake were not associated. Thus, there is no consensus regarding the factors associated with the prevalence and severity of menstrual-related symptoms. Therefore, we aimed to identify factors associated with the prevalence and severity of menstrual-related symptoms by conducting a systematic review and meta-analysis. The significance of this study is that by identifying the factors associated with the prevalence and severity of menstrual-related symptoms, an appropriate strategy to improve menstrual-related symptoms and support women’s health could be developed.

2. Materials and Methods

This systematic review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) protocols [7]. The study protocol was registered in the PROSPERO database (registration ID: CRD42021208432).

2.1. Study Selection

A literature search was conducted using PubMed and Ichushi-Web (an exhaustive collection of Japanese biomedical literature) (Table 1). The search was performed on 15 January 2021. The following inclusion criteria were applied: (1) written in English and Japanese; and (2) observational studies (cross-sectional studies, cohort studies, and case-control studies). The following exclusion criteria were applied: (1) the participants were not human; (2) the participants included men; (3) the participants included women with diseases, pregnant women, and premenopausal or postmenopausal women; (4) the studies did not describe the characteristics of the participants; (5) the studies did not assess PD and PMS; and (6) the studies did not examine factors related to the prevalence and severity of PD and PMS.
Studies were independently screened by two reviewers (R.M. and A.S.), first by title and abstract, and next by full text according to the inclusion and exclusion criteria. In case of discrepancies in the screening results, a third reviewer (Y.N.) was added to the discussion and the issue was resolved by consensus among the three reviewers.

2.2. Data Extraction

The two independent reviewers extracted the following data from the eligible studies: name of first author; publication year; country; study design; sample size; and sample characteristics, including age, outcome measures, and exposure outcomes.

2.3. Quality Assessment

The two independent reviewers evaluated the quality of the included study according to the Jonna Briggs Institute (JBI) critical appraisal checklist [8]. The JBI evaluates bias by selecting the closest answer to a specific question from Yes, No, unclear, or not applicable. On completion of the evaluations, the JBI score, which comprised the percentage of “yes” responses, was calculated for each study. The studies with a JBI score ≥ 50% and <70% were considered as having middle quality, while the studies with a JBI score ≥ 70% were considered as having high quality; these studies with middle or high quality were included in our meta-analysis. In cases of discrepancies in the results, the third reviewer was added to the discussion and the issue was resolved by consensus among the three reviewers.

2.4. Statistical Analysis

Statistical analysis and meta-analysis were performed using Review Manager software version 5.4 (The Nordic Cochrane Centre, Copenhagen, Denmark). We used the random-effects models to calculate each outcome’s risk regarding prevalence and severity (mild, moderate, or severe) for PD and PMS. The effect size was reported as odds ratio (OR) and its 95% confidence interval (CI).

3. Results

3.1. Study Selection

A flow diagram outlining the study selection in this systematic review and meta-analysis is presented in Figure 1. A total of 1479 studies were retrieved in the database search: 1299 from PubMed, and 180 from Ichushi-Web. Of these studies, three were duplicated.
After screening the titles and abstracts of 1476 studies, 1108 that did not meet the inclusion criteria were excluded. After screening the full text of 368 studies, 237 were excluded. The risk of bias of the remaining 131 studies was evaluated using the JBI score (Supplementary Table S1); among these, 31 (JBI score ≥ 70%) [5,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38], 46 (JBI score ≥ 50% and <70%) [6,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83], and 54 (JBI score < 50%) [84,85,86,87,88,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,117,118,119,120,121,122,123,124,125,126,127,128,129,130,131,132,133,134,135,136,137] were of high, middle, and low quality, respectively. Hence, 54 studies were excluded. Finally, 77 studies were included in the meta-analysis.

3.2. Characteristics of the Included Studies

Of the 77 studies, 44 were cross-sectional, 30 were case-control, and 3 were cohort studies. Moreover, 31 examined PD, 26 examined PMS, 15 examined PMS and premenstrual dysphoric disorder (PMDD), and 3 examined PMDD. The remaining two studies examined factors of PD and PMS as well as PD, PMS, and PMDD, respectively.

3.3. Primary Dysmenorrhea

3.3.1. Characteristics of Reporting of PD

The timing of the onset of PD symptoms was reported in seven studies [6,13,45,59,64,66,68] (Table 2). The proportion of symptoms occurring from the first day of menstruation was the highest in all seven studies (31.6–70.0%). The timing of the onset of PMS symptoms was not reported.
The duration of PD was reported in eight studies [6,13,23,44,53,59,66,68]. Among them, two studies [23,44] reported the mean ± standard deviation (SD). Three more studies [6,59,68] reported the proportion, and the others reported the most frequent days [13,53,66], the mean days [13,53,66], and the median and 25th/75th percentile [13,53,66] (Table 3).
The effects of PD were reported in five studies [45,66,68,73,83] (Table 4). The effect of PD on work or school was reported in four studies (4.4–44.7%). The effect of PD on daily life was reported in three studies (54.5–92.4%), and of these two studies reported that the impact on daily life was highest.
The methods of coping with symptoms of PD were reported in four studies [21,45,68,75] (Table 5). All four studies reported the use of analgesics (32.5–67.0%), and in three of these studies, the use of analgesics (39.9–67.0%) was highest.
Details of the symptoms of PD were reported in 10 studies [5,6,30,38,44,45,58,68,72,75], and 9 of the 10 studies reported the prevalence [5,6,30,38,44,58,68,72,75] (Supplementary Table S2). The following 17 symptoms were reported in descending order of frequency: nausea, fatigue, abdominal pain, diarrhea, headache, low back pain, irritability, dizziness, decreased concentration, changes in sleep, depression, anxiety-tension, mood depression, changes in appetite, inflammation of the skin, edema, and lack of interest.

3.3.2. Risk Factors for PD

From the 77 studies, we extracted data regarding (1) physical characteristics, such as age, body mass index (BMI), and race; (2) menstrual characteristics, such as age at menarche, number of menstrual days, menstrual cycle, and family history of PD; and (3) lifestyle factors, such as stress, smoking habit, alcohol intake, caffeine intake, skipping breakfast, physical activity, sleep duration, and bedtime. The meta-analysis revealed that eight factors were significantly associated with the prevalence of PD: age ≥ 20 years (OR: 1.18; 95% CI: 1.04–1.34) (Figure 2); BMI < 18.5 kg/m2 (OR: 1.51; 95% CI: 1.01–2.26) (Figure 3); longer menstrual periods (OR: 0.16; 95% CI: 0.04–0.28) (Figure 4); irregular menstrual cycle (OR: 1.28; 95% CI: 1.13–1.45) (Figure 5); family history of PD (OR: 3.80; 95% CI: 2.18–6.61) (Figure 6); stress (OR: 1.88; 95% CI: 1.30–2.72) (Figure 7); sleeping for <7 h (OR: 1.19; 95% CI: 1.04–1.35) (Figure 8); and bedtime after 23:01 (OR: 1.30; 95% CI: 1.16–1.45) (Figure 9). A significant OR was found for two factors associated with the severity of PD (severe vs. moderate): BMI < 18.5 kg/m2 (OR: 1.89; CI: 1.01−3.54) (Figure 10) and smoking habit (OR: 1.94; 95% CI: 1.08–3.47) (Figure 11). The severity of PD (severe vs. mild) was significantly associated with BMI < 18.5 kg/m2 (OR: 1.91; 95% CI: 1.04–3.50) (Figure 12).

3.4. Premenstrual Syndrome

3.4.1. Characteristics of Reporting of PMS

The timing of the onset of PMS symptoms was not reported. The duration of PMS was reported in one study [50]. This study reported that the mean ± standard deviation (SD) was 7.1 ± 3.5 (days).
The effects of PMS were reported in two studies [54,73] (Table 6). These two studies reported the effect of PMS on work or school (42.9−44.7%). Among these, one study [54] reported the effect of PMS on daily life (71.3%) and relationships (48.0%), in addition to the impact on work and school, the highest impact on daily life.
The methods of coping with symptoms of PMS were reported in one study [67]. This study reported the use of analgesics (45.6%), warming (25.0%), rest (21.9%), and exercise (7.9%). The use of analgesics was highest.
Details of the symptoms of PMS were reported in 18 studies [11,17,18,19,27,30,32,39,40,46,50,54,56,57,62,63,73,90], and 14 of the 18 studies reported the prevalence [11,17,18,19,27,30,39,40,46,50,54,57,63,73] (Supplementary Table S3). The following 24 symptoms were reported in the descending order of frequency: irritability, fatigue, anxiety-tension, fatigue, changes in appetite, changes in sleep, breast tenderness, headache, decreased concentration, abdominal pain, low back pain, tearfulness, inflammation of the skin, edema, decreased interest, abdominal distension, nausea, mood elevation, cramps, depressed mood, diarrhea, muscle tension, hot flashes, and dizziness.

3.4.2. Risk Factors for PMS

From the 77 studies, we extracted data regarding (1) physical characteristics, such as age, body mass index (BMI), and race; (2) menstrual characteristics, such as age at menarche, number of menstrual days, menstrual cycle, and family history of PD; and (3) lifestyle factors, such as stress, smoking habit, alcohol intake, caffeine intake, skipping breakfast, physical activity, sleep duration, and bedtime. The meta-analysis revealed that the prevalence of PMS was significantly associated with smoking (OR: 1.86; 95% CI: 1.31–2.66) (Figure 13).

4. Discussion

4.1. Principal Findings

This study aimed to identify factors associated with the prevalence and severity of menstrual-related symptoms. As a result, significant ORs were observed for some of the physical characteristics, menstrual characteristics, and lifestyle factors.
Regarding physical characteristics, age and BMI were significantly associated with the prevalence of PD, and BMI was associated with the severity of PD. PD is known to be more common during the late teens compared to during the early twenties, peaking around age 20 and decreasing thereafter [138]. Two of the studies included in the present meta-analysis, both of which involved university students in their teens and twenties, revealed that the prevalence of PD decreased with increasing age. This supports the findings of a previous study [138]. Considering low BMI values, it is known that normal reproductive development and menarche require adequate body fat mass. A previous study reported that a body fat percentage of at least 17% should be maintained for the onset of menarche and at least 22% is required for regular menstruation [139]. In addition, low available energy, which is associated with low BMI, leads to the disruption of the hypothalamus–pituitary system [139,140]. Disorders of the hypothalamus–pituitary system cause amenorrhea and abnormal menstruation by inhibiting the secretion of luteinizing hormone and follicle-stimulating hormone from the pituitary gland and blocking stimulation of the ovaries [139,140]. Furthermore, Ju et al. [141] reported a U-shaped relationship between the body fat percentage and the prevalence of PD; high BMI has been reported to cause early menarche, irregular menstrual cycles, rare menstruation, amenorrhea, and chronic anovulation [142]. This suggests that, in addition to low BMI, high BMI may also increase the prevalence and severity of PD. Therefore, maintaining an appropriate BMI may reduce the prevalence and severity of PD.
Regarding the characteristics of menstruation, the number of menstrual days, menstrual cycle, and family history of PD were significantly associated with the prevalence of PD. PD is known to result from uterine contractions caused by pain-inducing prostaglandins [143]. Prostaglandins are normally secreted during menstruation to expel the endometrium. However, prostaglandins also cause local vasoconstriction, and excessive prostaglandin secretion causes uterine ischemia and pain, resulting in PD [143]. In addition, longer menstrual periods increase the duration of prostaglandin secretion, which may lead to longer durations and more severe pain. The disruption of the hypothalamus–pituitary system and the blockage of ovarian stimulation cause discontinuation of estrogen production. When the production of estrogen is disrupted, the balance of female hormones is disturbed, resulting in an irregular menstrual cycle [139,144]. Pertaining to family history of PD, Jahanfar et al. [105] examined the genetic factors in menstruation-related problems in monozygotic and dizygotic twins and reported that 40−50% were related to genetic factors. It may also be relevant that approximately 56% of information sources regarding girls’ pain management and menstruation are mothers [145].
For lifestyle factors, stress, sleep duration, and sleeping time were significantly associated with the prevalence of PD. Smoking was also associated with the prevalence of PMS. Female reproductive organs are believed to be highly sensitive to stress, and intense stress could have detrimental effects on health [40,146]. Activation of the corticotropin-releasing hormone system by elevated stress levels inhibits the release of follicle-stimulating hormone and luteinizing hormone, thereby inhibiting follicle development [40,146]. Stress-related hormones such as adrenaline and cortisol can also increase prostaglandin synthesis and cause PD [146]. Additionally, short sleep duration was suggested to lead to a decrease in melatonin secretion [147]. Regarding the effects of melatonin on sexual function, a pituitary−gonadal function is reduced during winter, when melatonin secretion is lower [148], and melatonin administration to neonates causes sexual prematurity [149,150]. Therefore, melatonin secretion may affect reproductive function. In contrast, the occurrence of PD itself was reported to reduce sleep duration; therefore, a causal relationship is unclear [20].
The present study revealed no significant ORs for physical activity, alcohol consumption, caffeine intake, and breakfast skipping.
Physical activity promotes the release of endorphins in the blood that reduces pain, exerts a relaxing effect on muscle [151], reduces cortisol levels, and reduces the synthesis of prostaglandins that cause pain [152]. For these reasons, physical activity has been shown to be effective in improving PD, suggesting an association between physical activity and PD [151]. However, no association was identified in the present study. The reason could be attributed to differences in exercise intensity. The results of the present study by age group indicated that more studies involving teenagers and participants in the twenties suggested an association with PD and PMS than studies targeting those aged ≥30 years. This may be attributed to the fact that the definition of exercise differed according to the age group. Especially, studies of women in their teens and twenties defined high-intensity exercise, such as performing sports club activities, while studies of women in their thirties and older defined and included low-intensity exercises, such as walking. In a previous study that examined factors associated with the prevalence of PD in female athletes and non-athletes, only non-athletes showed an association between exercise and the prevalence of PD, and the reason for this association might have been exercise intensity [153]. Therefore, exercise intensity should be considered when examining the association between physical activity or exercise and prevalence and severity of PD and PMS.
For alcohol and caffeine intake, over-contraction of the uterus has been shown to decrease blood flow in the uterus and cause pain [154,155]. Caffeine has been demonstrated to increase uterine contractions [156], and alcohol consumption reduces uterine arterial blood flow by approximately 40% [157]. However, no significant ORs were identified in the meta-analysis of the present study. This difference could be attributed to varying definitions of alcohol and caffeine consumption. Specifically, among the studies included in the present meta-analysis, the criterion of a study [6] of Chinese university students was one glass of wine per month in the past 6 months (approximately 250 mL), whereas the criterion for having alcohol consumption in a study including Turkish university student was ≥1 drink/week [56].
Regarding caffeine intake, one criterion was ≥300 mg of caffeinated soft drinks, coffee, decaf coffee, black tea, chocolate milk, and chocolate bars in a study involving Iranian university students [5], whereas in another study involving Chinese university students, the criterion was the consumption of three or more caffeine-containing substances, such as coffee, tea, and chocolate in the past month [6]. These differences in definitions may have led to the conflicting results.
Skipping breakfast also leads to a lower intake of certain foods, and it is suggested that nutritional imbalances may lead to PD [20]. In addition, dairy products and dietary fiber, which are commonly consumed at breakfast, show a significant association with PD, and a lower intake of these nutrients may increase the risk of PD [84,158,159]. Additionally, it was noted that missing breakfast may interfere with diurnal rhythms and negatively affect reproductive function [159], and there may be a link between eating habits and the development of PD and PMS. However, no significant ORs were identified in the present meta-analysis. The first reason for this discrepancy could be the effect of cultural background. Three studies were included in the meta-analysis regarding skipping breakfast: one study of Iranian university students [5], another of Chinese university students [6], and the other of Japanese junior high school students [20]. These cultural differences may be related to the lack of association. Second, each study had a different definition of skipping breakfast. The study of Iranian university students defined skipping breakfast as having breakfast ≤ 1 time per week, whereas the definition in the study involving Chinese university students was not eating breakfast more than once in the past week; the definition used in the study of Japanese junior high school students was occasional or no breakfast intake. Therefore, in the future, consideration of the cultural background with the associated definition of skipping breakfast is necessary to assess the association of each item with the occurrence and severity of symptoms associated with menstruation.

4.2. Strengths and Limitations

Many studies have investigated the factors associated with menstrual symptoms in the past few decades. Most of them focus on dysmenorrhea occurring during menstruation [5,6,10,20,28,34,38,58,66,68,83] or premenstrual syndrome occurring before menstruation [32,43,70]. However, many women experience symptoms associated with menstruation both before and during menstruation, rather than only before or during menstruation. Moreover, the discrimination between premenstrual and menstrual symptoms was suggested to be meaningless because the types of symptoms were similar [160]. Furthermore, several factors were associated with the development of menstrual symptoms, and the degree of influence of these factors should be clarified. Therefore, the present systematic review and meta-analysis tried to synthesize the findings of previous publications on pre-menstrual syndromes, which occurs before menstruation, and dysmenorrhea, which occurs during menstruation. To our knowledge, our study is the first to identify factors associated with the prevalence and severity of these symptoms.
Nevertheless, this study has several limitations. First, many of the symptoms associated with menstruation are self-reported and may include conditions such as organic dysmenorrhea. Of the 34 studies [5,6,9,10,12,20,22,23,24,28,29,30,32,34,35,37,38,41,43,49,55,58,59,60,61,65,66,68,69,70,72,75,80,83] from which meta-analysis data could be extracted for this study, 21 studies [5,6,9,12,20,29,30,32,34,37,38,43,58,59,66,68,70,72,75,80,83] used a self-response questionnaire, and PD and PMS were assessed by the participant, without being examined by a physician. Second, causality of the factors associated with menstrual symptoms is unclear. Many of the studies accepted for inclusion in the systematic review of this study were cross-sectional studies and did not examine causality. For case-control studies [10,22,23,24,28,33,35,41,49,55,60,61,65], only cross-sectional data at the start of the study were extracted. Third, racial and ethnic differences are not considered. The study participants of the included studies in the present systematic review were predominantly from the United States and Turkey. Finally, only 34 of the 77 studies were included in the meta-analysis because we could extract comparable data for the meta-analysis concerning three topics: physical characteristics, menstrual characteristics, and lifestyle. Each analysis had a small number of studies. Therefore, generalizability of the present study is limited.

4.3. Future Direction

The present study enabled the identification of factors associated with the prevalence and severity of menstrual-related symptoms. Among these, BMI, stress, sleep duration, and bedtime, which were found to be associated with the prevalence of PD; BMI, which was found to be associated with the severity of PD; and smoking, which was found to be associated with PMS, are items that can be improved through one’s own behaviors. Therefore, the results of this study may help women review their own lives according to their individual symptoms and choose behaviors to improve these symptoms.

5. Conclusions

The present systematic review and meta-analysis were performed to identify factors associated with the prevalence and severity of PD and PMS. The results suggest that physical characteristics, such as age and BMI; menstrual characteristics, such as longer menstrual periods, irregular menstrual cycle, and family history of PD; and lifestyle factors, such as smoking, sleeping hours, bedtime, and stress were associated with the prevalence and severity of menstrual-related symptoms.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/ijerph20010569/s1, Table S1: Characteristics of included studies. Table S2: Details if the symptoms of primary dysmenorrhea. Table S3: Details if the symptoms of premenstrual syndrome.

Author Contributions

Conceptualization, R.M. and Y.N.; methodology, R.M., A.S., K.K. and Y.N.; formal analysis, R.M.; validation, R.M., K.K. and Y.N.; investigation, R.M. and Y.N.; data curation, R.M., A.S. and Y.N.; writing—original draft preparation, R.M. and Y.N.; writing—review and editing, R.M. and Y.N.; visualization, R.M. and Y.N.; supervision, H.S. and Y.N.; project administration, Y.N. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

We sincerely thank the colleagues of our laboratory.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Farage, M.A.; Neill, S.; MacLean, A.B. Physiological changes associated with the menstrual cycle: A review. Obstet. Gynecol. Surv. 2009, 64, 58–72. [Google Scholar] [CrossRef]
  2. De Sanctis, V.; Soliman, A.T.; Elsedfy, H.; Soliman, N.A.; Soliman, R.; El Kholy, M. Dysmenorrhea in adolescents and young adults: A review in different country. Acta Biomed. 2016, 87, 233–246. [Google Scholar]
  3. Bernardi, M.; Lazzeri, L.; Perelli, F.; Reis, F.M.; Petraglia, F. Dysmenorrhea and related disorders. F1000Research 2017, 6, 1645. [Google Scholar] [CrossRef] [Green Version]
  4. Direkvand-Moghadam, A.; Sayehmiri, K.; Delpisheh, A.; Sattar, K. Epidemiology of Premenstrual Syndrome (PMS)—A systematic review and meta-analysis study. J. Clin. Diagn. Res. 2014, 8, 106–109. [Google Scholar]
  5. Faramarzi, M.; Salmalian, H. Association of psychologic and nonpsychologic factors with primary dysmenorrhea. Iran. Red Crescent Med. J. 2014, 16, e16307. [Google Scholar] [CrossRef] [Green Version]
  6. Hu, Z.; Tang, L.; Chen, L.; Kaminga, A.C.; Xu, H. Prevalence and risk factors associated with primary dysmenorrhea among Chinese female university students: Across–sectional study. J. Pediatr. Adolesc. Gynecol. 2020, 33, 15–22. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Moher, D.; Liberati, A.; Tetzlaff, J.; Altman, D.G. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009, 6, e1000097. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. The Joaanna Briggs Institute. The Joanna Briggs Institute Meta-Analysis of Statistics Assessment and Review Instrument. Available online: https://jbi.global/critical-appraisal-tools (accessed on 23 December 2021).
  9. Abadi Bavil, D.; Dolatian, M.; Mahmoodi, Z.; Akbarzadeh Baghban, A. A comparison of physical activity and nutrition in young women with and without primary dysmenorrhea. F1000Research 2018, 7, 59. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  10. Aksoy, A.N.; Laloglu, E.; Ozkaya, A.L.; Yilmaz, E.P.T. Serum heme oxygenase–1 levels in patients with primary dysmenorrhea. Arch. Gynecol. Obstet. 2017, 295, 929–934. [Google Scholar] [CrossRef]
  11. Azoulay, M.; Reuveni, I.; Dan, R.; Goelman, G.; Segman, R.; Kalla, C.; Bonne, O.; Canetti, L. Childhood trauma and premenstrual symptoms: The role of emotion regulation. Child Abus. Negl. 2020, 108, 104637. [Google Scholar] [CrossRef]
  12. Bahrami, A.; Bahrami–Taghanaki, H.; Khorasanchi, Z.; Timar, A.; Jaberi, N.; Azaryan, E.; Tayefi, M.; Ferns, G.A.; Sadeghnia, H.R.; Ghayour–Mobarhan, M. Menstrual problems in adolescence: Relationship to serum vitamins A and E, and systemic inflammation. Arch. Gynecol. Obstet. 2020, 301, 189–197. [Google Scholar] [CrossRef] [PubMed]
  13. Balbi, C.; Musone, R.; Menditto, A.; Di Prisco, L.; Cassese, E.; D'Ajello, M.; Ambrosio, D.; Cardone, A. Influence of menstrual factors and dietary habits on menstrual pain in adolescence age. Eur. J. Obstet. Gynecol. Reprod. Biol. 2000, 91, 143–148. [Google Scholar] [CrossRef]
  14. Bertone-Johnson, E.R.; Chocano-Bedoya, P.O.; Zagarins, S.E.; Micka, A.E.; Ronnenberg, A.G. Dietary vitamin D intake, 25-hydroxyvitamin D3 levels and premenstrual syndrome in a college-aged population. J. Steroid Biochem. Mol. Biol. 2010, 121, 434–437. [Google Scholar] [CrossRef] [PubMed]
  15. Dhingra, V.; Magnay, J.L.; O'Brien, P.M.S.; Chapman, G.; Fryer, A.A.; Ismail, K.M. Serotonin receptor 1A C (-1019) G polymorphism associated with premenstrual dysphoric disorder. Obstet. Gynecol. 2007, 110, 788–792. [Google Scholar] [CrossRef] [PubMed]
  16. Duan, G.; Liu, H.; Pang, Y.; Liu, P.; Liu, Y.; Wang, G.; Liao, H.; Tang, L.; Chen, W.; Mo, X. Hippocampal fractional amplitude of low-frequency fluctuation and functional connectivity changes in premenstrual syndrome. J. Magn. Reson. Imaging 2018, 47, 545–553. [Google Scholar] [CrossRef] [PubMed]
  17. Gollenberg, A.L.; Hediger, M.L.; Mumford, S.L.; Whitcomb, B.W.; Hovey, K.M.; Wactawski-Wende, J.; Schisterman, E.F. Perceived stress and severity of perimenstrual symptoms: The BioCycle Study. J. Womens Health 2010, 19, 959–967. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  18. Isgin-Atici, K.; Buyuktuncer, Z.; Akgül, S.; Kanbur, N. Adolescents with premenstrual syndrome: Not only what you eat but also how you eat matters! J. Pediatr. Endocrinol. Metab. 2018, 31, 1231–1239. [Google Scholar] [CrossRef] [PubMed]
  19. Jarosz, A.C.; El-Sohemy, A. Association between Vitamin D Status and Premenstrual Symptoms. J. Acad. Nutr. Diet. 2019, 119, 115–123. [Google Scholar] [CrossRef] [PubMed]
  20. Kazama, M.; Maruyama, K.; Nakamura, K. Prevalence of dysmenorrhea and its correlating lifestyle factors in Japanese female junior high school students. Tohoku J. Exp. Med. 2015, 236, 107–113. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  21. Kordi, M.; Mohamadirizi, S.; Shakeri, M.T. The relationship between occupational stress and dysmenorrhea in midwives employed at public and private hospitals and health care centers in Iran (Mashhad) in the years 2010 and 2011. Iran. J. Nurs. Midwifery Res. 2013, 18, 316–322. [Google Scholar]
  22. Liao, H.; Pang, Y.; Liu, P.; Liu, H.; Duan, G.; Liu, Y.; Tang, L.; Tao, J.; Wen, D.; Li, S. Abnormal spontaneous brain activity in women with premenstrual syndrome revealed by regional homogeneity. Front. Hum. Neurosci. 2017, 11, 62. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Liu, J.; Liu, H.; Mu, J.; Xu, Q.; Chen, T.; Dun, W.; Yang, J.; Tian, J.; Hu, L.; Zhang, M. Altered white matter microarchitecture in the cingulum bundle in women with primary dysmenorrhea: A tract-based analysis study. Hum. Brain Mapp. 2017, 38, 4430–4443. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Liu, P.; Liu, Y.; Wang, G.; Li, R.; Wei, Y.; Fan, Y.; Yu, Y.; Deng, D.; Qin, W. Changes of functional connectivity of the anterior cingulate cortex in women with primary dysmenorrhea. Brain Imaging Behav. 2018, 12, 710–717. [Google Scholar] [CrossRef] [PubMed]
  25. Liu, P.; Wei, Y.; Fan, Y.; Li, R.; Liu, Y.; Wang, G.; Wei, Y.; Pang, Y.; Deng, D.; Qin, W. Altered brain structure in women with premenstrual syndrome. J. Affect. Disord. 2018, 229, 239–246. [Google Scholar] [CrossRef] [PubMed]
  26. Liu, P.; Wei, Y.; Fan, Y.; Liao, H.; Wang, G.; Li, R.; Duan, G.; Deng, D.; Qin, W. Cortical and subcortical changes in patients with premenstrual syndrome. J. Affect. Disord. 2018, 235, 191–197. [Google Scholar] [CrossRef]
  27. Mustaniemi, S.; Sipola-Leppänen, M.; Hovi, P.; Halbreich, U.; Vääräsmäki, M.; Räikkönen, K.; Pesonen, A.K.; Heinonen, K.; Järvenpää, A.L.; Eriksson, J.G. Premenstrual symptoms in young adults born preterm at very low birth weight-from the Helsinki Study of very low birth weight adults. BMC Women’s Health 2011, 11, 25. [Google Scholar] [CrossRef] [Green Version]
  28. Najafi, N.; Khalkhali, H.; Moghaddam Tabrizi, F.; Zarrin, R. Major dietary patterns in relation to menstrual pain: A nested case control study. BMC Women’s Health 2018, 18, 69. [Google Scholar] [CrossRef] [Green Version]
  29. Nicolau, Z.F.M.; Bezerra, A.G.; Polesel, D.N.; Andersen, M.L.; Bittencourt, L.; Tufik, S.; Hachul, H. Premenstrual syndrome and sleep disturbances: Results from the Sao Paulo Epidemiologic Sleep Study. Psychiatry Res. 2018, 264, 427–431. [Google Scholar] [CrossRef]
  30. Nisar, N.; Zehra, N.; Haider, G.; Munir, A.A.; Sohoo, N.A. Frequency, intensity and impact of premenstrual syndrome in medical students. J. Coll. Physicians Surg. Pak. 2008, 18, 481–484. [Google Scholar]
  31. Perkonigg, A.; Yonkers, K.A.; Pfister, H.; Lieb, R.; Wittchen, H.U. Risk factors for premenstrual dysphoric disorder in a community sample of young women: The role of traumatic events and posttraumatic stress disorder. J. Clin. Psychiatry 2004, 65, 1314–1322. [Google Scholar] [CrossRef]
  32. Quintana–Zinn, F.A.; Whitcomb, B.W.; Ronnenberg, A.G.; Bigelow, C.; Houghton, S.C.; Bertone–Johnson, E.R. Premenstrual symptom patterns and behavioral risk factors in young women: A cross–sectional study. J. Womens Health 2017, 26, 1099–1105. [Google Scholar] [CrossRef] [PubMed]
  33. Roomruangwong, C.; Sirivichayakul, S.; Carvalho, A.F.; Maes, M. The uterine–chemokine–brain axis: Menstrual cycle–associated symptoms (MCAS) are in part mediated by CCL2, CCL5, CCL11, CXCL8 and CXCL10. J. Affect. Disord. 2020, 269, 85–93. [Google Scholar] [CrossRef] [PubMed]
  34. Tomás-Rodríguez, M.I.; Palazón-Bru, A.; Martínez-St John, D.R.; Navarro-Cremades, F.; Toledo-Marhuenda, J.V.; Gil-Guillén, V.F. Factors associated with increased pain in primary dysmenorrhea: Analysis using a multivariate ordered logistic regression model. J. Pediatr. Adolesc. Gynecol. 2017, 30, 199–202. [Google Scholar] [CrossRef] [PubMed]
  35. Turhan, N.; Çelik, H.; Duvan, C.İ.; Onaran, Y.; Aydın, M.; Armutcu, F. Investigation of oxidative balance in patients with dysmenorrhea by multiple serum markers. J. Turk. Ger. Gynecol. Assoc. 2012, 13, 233. [Google Scholar] [CrossRef]
  36. Woods, N.F.; Lentz, M.J.; Mitchell, E.S.; Kogan, H. Arousal and stress response across the menstrual cycle in women with three perimenstrual symptom patterns. Res. Nurs. Health 1994, 17, 99–110. [Google Scholar] [CrossRef] [PubMed]
  37. Yoshimi, K.; Shiina, M.; Takeda, T. Lifestyle factors associated with premenstrual syndrome: Across–sectional study of Japanese high school students. J. Pediatr. Adolesc. Gynecol. 2019, 32, 590–595. [Google Scholar] [CrossRef]
  38. Zurawiecka, M.; Wronka, I. Association of primary dysmenorrhea with anthropometrical and socio-economic factors in Polish university students. J. Obstet. Gynaecol. Res 2018, 44, 1259–1267. [Google Scholar] [CrossRef]
  39. Ader, D.N.; South-Paul, J.; Adera, T.; Deuster, P.A. Cyclical mastalgia: Prevalence and associated health and behavioral factors. J. Psychosom. Obstet. Gynaecol. 2001, 22, 71–76. [Google Scholar] [CrossRef]
  40. Ansong, E.; Arhin, S.K.; Cai, Y.; Xu, X.; Wu, X. Menstrual characteristics, disorders and associated risk factors among female international students in Zhejiang Province, China: A cross-sectional survey. BMC Womens Health 2019, 19, 35. [Google Scholar] [CrossRef] [Green Version]
  41. Baker, F.C.; Kahan, T.L.; Trinder, J.; Colrain, I.M. Sleep quality and the sleep electroencephalogram in women with severe premenstrual syndrome. Sleep 2007, 30, 1283–1291. [Google Scholar] [CrossRef] [Green Version]
  42. Beck, L.E.; Gevirtz, R.; Mortola, J.F. The predictive role of psychosocial stress on symptom severity in premenstrual syndrome. Psychosom. Med. 1990, 25, 536–543. [Google Scholar] [CrossRef] [PubMed]
  43. Bryant, M.; Truesdale, K.P.; Dye, L. Modest changes in dietary intake across the menstrual cycle: Implications for food intake research. Br. J. Nutr. 2006, 96, 888–894. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Carman, K.B.; Arslantas, D.; Unsal, A.; Atay, E.; Ocal, E.E.; Demirtas, Z.; Saglan, R.; Dinleyici, M.; Yarar, C. Menstruation-related headache in adolescents: Point prevalence and associated factors. Pediatr. Int. 2018, 60, 576–580. [Google Scholar] [CrossRef] [PubMed]
  45. Chen, H.M.; Chen, C.H. Related factors and consequences of menstrual distress in adolescent girls with dysmenorrhea. Kaohsiung J. Med. Sci. 2005, 21, 121–127. [Google Scholar] [CrossRef]
  46. Cleckner-Smith, C.S.; Doughty, A.S.; Grossman, J.A. Premenstrual symptoms. Prevalence and severity in an adolescent sample. J. Adolesc. Health 1998, 22, 403–408. [Google Scholar] [CrossRef]
  47. Deng, D.; Pang, Y.; Duan, G.; Liu, H.; Liao, H.; Liu, P.; Liu, Y.; Li, S.; Chen, W.; Wen, D.; et al. Larger volume and different functional connectivity of the amygdala in women with premenstrual syndrome. Eur. Radiol. 2018, 28, 1900–1908. [Google Scholar] [CrossRef]
  48. Dmitrovic, R.; Peter, B.; Cvitkovic-Kuzmic, A.; Strelec, M.; Kereshi, T. Severity of symptoms in primary dysmenorrhea—A Doppler study. Eur. J. Obstet. Gynecol. Reprod. Biol. 2003, 107, 191–194. [Google Scholar] [CrossRef]
  49. Engin–Ustün, Y.; Ustün, Y.; Gürdal, H.; Güngör, M. Serotonergic activity and the Beck Depression Inventory in the premenstrual syndrome. J. Reprod. Med. 2005, 50, 327–331. [Google Scholar]
  50. Farahmand, M.; Ramezani Tehrani, F.; Khalili, D.; Amin, G.; Negarandeh, R. Factors associated with the severity of premenstrual syndrome among Iranian college students. J. Obstet. Gynaecol. Res. 2017, 43, 1726–1731. [Google Scholar] [CrossRef]
  51. Gurguis, G.N.; Yonkers, K.A.; Blakeley, J.E.; Phan, S.P.; Williams, A.; Rush, A.J. Adrenergic receptors in premenstrual dysphoric disorder. II. Neutrophil beta2-adrenergic receptors: Gs protein coupling, phase of menstrual cycle and prediction of luteal phase symptom severity. Psychiatry Res. 1998, 79, 31–42. [Google Scholar] [CrossRef]
  52. Hallman, J.; Oreland, L.; Edman, G.; Schalling, D. Thrombocyte monoamine oxidase activity and personality traits in women with severe premenstrual syndrome. Acta Psychiatr. Scand. 1987, 76, 225–234. [Google Scholar] [CrossRef] [PubMed]
  53. Harlow, S.D.; Park, M. A longitudinal study of risk factors for the occurrence, duration and severity of menstrual cramps in a cohort of college women. Br. J. Obstet. Gynaecol. 1996, 103, 1134–1142. [Google Scholar] [CrossRef] [Green Version]
  54. Hashim, M.S.; Obaideen, A.A.; Jahrami, H.A.; Radwan, H.; Hamad, H.J.; Owais, A.A.; Alardah, L.G.; Qiblawi, S.; Al-Yateem, N.; Faris, M.A.E. Premenstrual syndrome is associated with dietary and lifestyle behaviors among university students: A cross-sectional study from Sharjah, UAE. Nutrients 2019, 11, 1939. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  55. Hou, L.; Huang, Y.; Zhou, R. Premenstrual syndrome is associated with altered cortisol awakening response. Stress 2019, 22, 640–646. [Google Scholar] [CrossRef] [PubMed]
  56. İşik, H.; Ergöl, Ş.; Aynioğlu, Ö.; Şahbaz, A.; Kuzu, A.; Uzun, M. Premenstrual syndrome and life quality in Turkish health science students. Turk. J. Med. Sci. 2016, 46, 695–701. [Google Scholar] [CrossRef]
  57. Kamat, S.V.; Nimbalkar, A.; Phatak, A.G.; Nimbalkar, S.M. Premenstrual syndrome in Anand District, Gujarat: A cross-sectional survey. J. Fam. Med. Prim. Care 2019, 8, 640–647. [Google Scholar]
  58. Khalid, M.; Jamali, T.; Ghani, U.; Shahid, T.; Ahmed, T.; Nasir, T. Severity and relation of primary dysmenorrhea and body mass index in undergraduate students of Karachi: A cross sectional survey. J. Pak. Med. Assoc. 2020, 70, 1299–1304. [Google Scholar]
  59. Kural, M.; Noor, N.N.; Pandit, D.; Joshi, T.; Patil, A. Menstrual characteristics and prevalence of dysmenorrhea in college going girls. J. Fam. Med. Prim. Care 2015, 4, 426–431. [Google Scholar]
  60. Liu, P.; Wang, G.; Liu, Y.; Yu, Q.; Yang, F.; Jin, L.; Sun, J.; Yang, X.; Qin, W.; Calhoun, V.D. White matter microstructure alterations in primary dysmenorrhea assessed by diffusion tensor imaging. Sci. Rep. 2016, 6, 25836. [Google Scholar] [CrossRef] [Green Version]
  61. Liu, P.; Wei, Y.; Liao, H.; Fan, Y.; Li, R.; Feng, N.; Duan, G.; Deng, D.; Qin, W. Thalamocortical dysconnectivity in premenstrual syndrome. Brain Imaging Behav. 2019, 13, 717–724. [Google Scholar] [CrossRef]
  62. Marván, M.L.; Díaz-Erosa, M.; Montesinos, A. Premenstrual symptoms in Mexican women with different educational levels. J. Psychol. 1998, 132, 517–526. [Google Scholar] [CrossRef] [PubMed]
  63. Matsumoto, T.; Egawa, M.; Kimura, T.; Hayashi, T. A potential relation between premenstrual symptoms and subjective perception of health and stress among college students: A cross-sectional study. BioPsychoSocial Med. 2019, 13, 26. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  64. Monday, I.; Anthony, P.; Olunu, E.; Otohinoyi, D.; Abiodun, S.; Owolabi, A.; Mobolaji, B.; Fakoya, A.O.J. Prevalence and correlation between diet and dysmenorrhea among high school and college students in Saint Vincent and Grenadines. Open Access Maced. J. Med. Sci. 2019, 7, 920–924. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  65. Njoku, U.C.; Amadi, P.U.; Agomuo, E.N.; Bhebhe, M. The relationship between pain and vascular function biomarkers in dysmenorrheal university students. Chonnam Med. J. 2020, 56, 186–190. [Google Scholar] [CrossRef] [PubMed]
  66. Orhan, C.; Çelenay, Ş.T.; Demirtürk, F.; Özgül, S.; Üzelpasacı, E.; Akbayrak, T. Effects of menstrual pain on the academic performance and participation in sports and social activities in Turkish university students with primary dysmenorrhea: A case control study. J. Obstet. Gynaecol. Res. 2018, 44, 2101–2109. [Google Scholar] [CrossRef]
  67. Pinar, G.; Colak, M.; Oksuz, E. Premenstrual Syndrome in Turkish college students and its effects on life quality. Sex. Reprod. Healthc. 2011, 2, 21–27. [Google Scholar] [CrossRef]
  68. Rafique, N.; Al-Sheikh, M.H. Prevalence of primary dysmenorrhea and its relationship with body mass index. J. Obstet. Gynaecol. Res. 2018, 44, 1773–1778. [Google Scholar] [CrossRef]
  69. Roomruangwong, C.; Matsumoto, A.K.; Michelin, A.P.; de Oliveira Semeão, L.; de Lima Pedrão, J.V.; Moreira, E.G.; Sirivichayakul, S.; Carvalho, A.; Barbosa, D.S.; Maes, M. The role of immune and oxidative pathways in menstrual cycle associated depressive, physio-somatic, breast and anxiety symptoms: Modulation by sex hormones. J. Psychosom. Res. 2020, 135, 110158. [Google Scholar] [CrossRef]
  70. Sahin, S.; Ozdemir, K.; Unsal, A. Evaluation of premenstrual syndrome and quality of life in university students. J. Pak. Med. Assoc. 2014, 64, 915–922. [Google Scholar]
  71. Seippel, L.; Bäckström, T. Luteal-phase estradiol relates to symptom severity in patients with premenstrual syndrome. J. Clin. Endocrinol. Metab. 1998, 83, 1988–1992. [Google Scholar] [CrossRef]
  72. Şentürk, Ş. Relation between uterine morphology and severity of primary dysmenorrhea. Turk. J. Obstet. Gynecol. 2020, 17, 84–89. [Google Scholar] [CrossRef] [PubMed]
  73. Tadakawa, M.; Takeda, T.; Monma, Y.; Koga, S.; Yaegashi, N. The prevalence and risk factors of school absenteeism due to premenstrual disorders in Japanese high school students—A school-based cross-sectional study. BioPsychoSocial Med. 2016, 10, 13. [Google Scholar] [CrossRef] [Green Version]
  74. Takeda, T.; Tadakawa, M.; Koga, S.; Nagase, S.; Yaegashi, N. Premenstrual symptoms and posttraumatic stress disorder in Japanese high school students 9 months after the great East-Japan earthquake. Tohoku J. Exp. Med. 2013, 230, 151–154. [Google Scholar] [CrossRef] [Green Version]
  75. Tangchai, K.; Titapant, V.; Boriboonhirunsarn, D. Dysmenorrhea in Thai adolescents: Prevalence, impact and knowledge of treatment. J. Med. Assoc. Thail. 2004, 87, S69–S73. [Google Scholar]
  76. Tu, C.H.; Niddam, D.M.; Chao, H.T.; Chen, L.F.; Chen, Y.S.; Wu, Y.T.; Yeh, T.C.; Lirng, J.F.; Hsieh, J.C. Brain morphological changes associated with cyclic menstrual pain. Pain 2010, 150, 462–468. [Google Scholar] [CrossRef] [PubMed]
  77. Wang, M.; Seippel, L.; Purdy, R.H.; Bãckström, T. Relationship between symptom severity and steroid variation in women with premenstrual syndrome: Study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20-one. J. Clin. Endocrinol. Metab. 1996, 81, 1076–1082. [Google Scholar]
  78. Woods, N.F.; Lentz, M.J.; Mitchell, E.S.; Heitkemper, M.; Shaver, J.; Henker, R. Perceived stress, physiologic stress arousal, and premenstrual symptoms: Group differences and intra-individual patterns. Res. Nurs. Health 1998, 21, 511–523. [Google Scholar] [CrossRef]
  79. Woods, N.F.; Lentz, M.J.; Mitchell, E.S.; Shaver, J.; Heitkemper, M. Luteal phase ovarian steroids, stress arousal, premenses perceived stress, and premenstrual symptoms. Res. Nurs. Health 1998, 21, 129–142. [Google Scholar] [CrossRef]
  80. Wronka, I.; Teul, I.; Marchewka, J. The influence of age at menarche on the prevalence of disorders of the menstrual cycle among healthy university students. Ann. Acad. Med. Stetin. 2013, 59, 94–98. [Google Scholar] [PubMed]
  81. Yokose, H.; Suzuki, M.; Konno, M.; Takahashi, S.; Ishihara, K.; Doi, Y.; Uchiyama, M. Factors associated with premenstrual dysphoric disorder in Japanese female college students. J. Pediatr. Adolesc. Gynecol. 2015, 19, 310–321. [Google Scholar]
  82. Zeynali, M.; Haghighian, H.K. Is there a relationship between serum vitamin D with dysmenorrhea pain in young women? J. Gynecol. Obstet. Hum. Reprod. 2019, 48, 711–714. [Google Scholar] [CrossRef] [PubMed]
  83. Zukri, S.M.; Naing, L.; Hamzah, T.N.T. Primary dysmenorrhea among medical and dental university students in Kelantan: Prevalence and associated factors. Int. Med. J. 2009, 16, 93–99. [Google Scholar]
  84. Abdul-Razzak, K.K.; Ayoub, N.M.; Abu-Taleb, A.A.; Obeidat, B.A. Influence of dietary intake of dairy products on dysmenorrhea. J. Obstet. Gynaecol. Res. 2010, 36, 377–383. [Google Scholar] [CrossRef]
  85. Adams, M.; McCrone, S. SRD5A1 genotype frequency differences in women with mild versus severe premenstrual symptoms. Issues Ment. Health Nurs. 2012, 33, 101–108. [Google Scholar] [CrossRef] [PubMed]
  86. Aktaş, D. Prevalence and factors affecting dysmenorrhea in female university students: Effect on general comfort level. Pain Manag. Nurs. 2015, 16, 534–543. [Google Scholar] [CrossRef]
  87. Al-Matouq, S.; Al-Mutairi, H.; Al-Mutairi, O.; Abdulaziz, F.; Al-Basri, D.; Al-Enzi, M.; Al-Taiar, A. Dysmenorrhea among high-school students and its associated factors in Kuwait. BMC Pediatr. 2019, 19, 80. [Google Scholar] [CrossRef]
  88. Alam, F.; Nayyar, S.; Richie, W.; Archibong, A.; Nayyar, T. Beta-arrestin1 levels in mononuclear leukocytes support depression scores for women with premenstrual dysphoric disorder. Int. J. Environ. Res. Public Health 2015, 13, 43. [Google Scholar] [CrossRef] [Green Version]
  89. Albsoul-Younes, A.; Alefishat, E.; Farha, R.A.; Tashman, L.; Hijjih, E.; AlKhatib, R. Premenstrual syndrome and premenstrual dysphoric disorders among Jordanian women. Perspect. Psychiatr. Care 2018, 54, 348–353. [Google Scholar] [CrossRef]
  90. Bakhshani, N.M.; Mousavi, M.N.; Khodabandeh, G. Prevalence and severity of premenstrual symptoms among Iranian female university students. J. Pak. Med. Assoc. 2009, 59, 205–208. [Google Scholar]
  91. Barcikowska, Z.; Wójcik-Bilkiewicz, K.; Sobierajska-Rek, A.; Grzybowska, M.E.; Wąż, P.; Zorena, K. Dysmenorrhea and associated factors among Polish women: A cross-sectional study. Pain Res. Manag. 2020, 2020, 6161536. [Google Scholar] [CrossRef]
  92. Buchpiguel, C.; Alavi, A.; Crawford, D.; Freeman, E.; Newberg, A. Changes in cerebral blood flow associated with premenstrual syndrome: A preliminary study. J. Psychosom. Obstet. Gynaecol. 2000, 21, 157–165. [Google Scholar] [CrossRef] [PubMed]
  93. Çoban, Ö.G.; Karakaya, D.; Önder, A.; İşleyen, Z.; Adanır, A.S. Association of premenstrual dysphoric disorder and eating behaviors among nursing students: A cross-sectional study. J. Pediatr. Adolesc. Gynecol. 2021, 34, 203–208. [Google Scholar] [CrossRef] [PubMed]
  94. Craner, J.R.; Sigmon, S.T.; Martinson, A.A.; McGillicuddy, M.L. Premenstrual disorders and rumination. J. Clin. Psychol. 2014, 70, 32–47. [Google Scholar] [CrossRef]
  95. Czajkowska, M.; Drosdzol-Cop, A.; Naworska, B.; Galazka, I.; Gogola, C.; Rutkowska, M.; Skrzypulec-Plinta, V. The impact of competitive sports on menstrual cycle and menstrual disorders, including premenstrual syndrome, premenstrual dysphoric disorder and hormonal imbalances. Ginekol. Pol. 2020, 91, 503–512. [Google Scholar] [CrossRef]
  96. Danborno, A.M.; Nwankwo, M.; Kure, J.; Eluwa, C. Prevalence of premenstrual syndrome and changes in blood pressure with menstrual cycle among university students. Niger. J. Physiol. Sci. 2018, 33, 117–124. [Google Scholar] [PubMed]
  97. Farrokh-Eslamlou, H.; Oshnouei, S.; Heshmatian, B.; Akbari, E. Premenstrual syndrome and quality of life in Iranian medical students. Sex. Reprod. Healthc. 2015, 6, 23–27. [Google Scholar] [CrossRef] [PubMed]
  98. Flug, D.; Largo, R.H.; Prader, A. Symptoms related to menstruation in adolescent Swiss girls: A longitudinal study. Ann. Hum. Biol. 1985, 12, 161–168. [Google Scholar] [CrossRef]
  99. Fujiwara, T.; Sato, N.; Awaji, H.; Sakamoto, H.; Nakata, R. Skipping breakfast adversely affects menstrual disorders in young college students. Int. J. Food Sci. Nutr. 2009, 60, 23–31. [Google Scholar] [CrossRef]
  100. Goker, A.; Artunc-Ulkumen, B.; Aktenk, F.; Ikiz, N. Premenstrual syndrome in Turkish medical students and their quality of life. J. Obstet. Gynaecol. 2015, 35, 275–278. [Google Scholar] [CrossRef]
  101. Gupta, M.; Dua, D.; Kaur, H.; Grover, S. Prevalence of premenstrual dysphoric disorder among school-going adolescent girls. Ind. Psychiatry J. 2019, 28, 198–202. [Google Scholar]
  102. Hammarbäck, S.; Damber, J.E.; Bäckström, T. Relationship between symptom severity and hormone changes in women with premenstrual syndrome. J. Clin. Endocrinol. Metab. 1989, 68, 125–130. [Google Scholar] [CrossRef]
  103. Hata, K.; Nozu, A.; Kawatani, M.; Nawata, K. Association between dietary intake and dysmenorrhea among female college studentes. Clin. Gynecol. Obstet. 2016, 70, 1079–1083. [Google Scholar]
  104. Issa, B.A.; Yussuf, A.D.; Olatinwo, A.W.; Ighodalo, M. Premenstrual dysphoric disorder among medical students of a Nigerian university. Ann. Afr. Med. 2010, 9, 118–122. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  105. Jahanfar, S.; Lye, M.S.; Krishnarajah, I.S. The heritability of premenstrual syndrome. Twin Res. Hum. Genet. 2011, 14, 433–436. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  106. Jorgensen, J.; Rossignol, A.M.; Bonnlander, H. Evidence against multiple premenstrual syndromes: Results of a multivariate profile analysis of premenstrual symptomatology. J. Psychosom. Res. 1993, 37, 257–263. [Google Scholar] [CrossRef]
  107. Katwal, P.C.; Karki, N.R.; Sharma, P.; Tamrakar, S.R. Dysmenorrhea and Stress among the Nepalese Medical Students. Kathmandu Univ. Med. J. (KUMJ) 2016, 14, 318–321. [Google Scholar] [PubMed]
  108. Koci, A.; Strickland, O. Relationship of adolescent physical and sexual abuse to perimenstrual symptoms (PMS) in adulthood. Issues Ment. Health Nurs. 2007, 28, 75–87. [Google Scholar] [CrossRef]
  109. Koshikawa, N.; Tatsunuma, T.; Furuya, K.; Seki, K. Prostaglandins and premenstrual syndrome. Prostaglandins Leukot. Essent. Fat. Acids 1992, 45, 33–36. [Google Scholar] [CrossRef]
  110. Lin, I.M.; Tsai, Y.C.; Peper, E.; Yen, C.F. Depressive mood and frontal alpha asymmetry during the luteal phase in premenstrual dysphoric disorder. J. Obstet. Gynaecol. Res. 2013, 39, 998–1006. [Google Scholar] [CrossRef]
  111. Lovick, T.A.; Guapo, V.G.; Anselmo-Franci, J.A.; Loureiro, C.M.; Faleiros, M.C.M.; Del Ben, C.M.; Brandão, M.L. A specific profile of luteal phase progesterone is associated with the development of premenstrual symptoms. Psychoneuroendocrinology 2017, 75, 83–90. [Google Scholar] [CrossRef] [Green Version]
  112. Lustyk, M.K.; Douglas, H.A.; Shilling, E.A.; Woods, N.F. Hemodynamic and psychological responses to laboratory stressors in women: Assessing the roles of menstrual cycle phase, premenstrual symptomatology, and sleep characteristics. Int. J. Psychophysiol. 2012, 86, 283–290. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  113. Lustyk, M.K.; Widman, L.; Becker Lde, L. Abuse history and premenstrual symptomatology: Assessing the mediating role of perceived stress. Women Health 2007, 46, 61–80. [Google Scholar] [CrossRef] [PubMed]
  114. Lustyk, M.K.; Widman, L.; Paschane, A.; Ecker, E. Stress, quality of life and physical activity in women with varying degrees of premenstrual symptomatology. Women Health 2004, 39, 35–44. [Google Scholar] [CrossRef] [PubMed]
  115. Magnay, J.L.; El-Shourbagy, M.; Fryer, A.A.; O'Brien, S.; Ismail, K.M. Analysis of the serotonin transporter promoter rs25531 polymorphism in premenstrual dysphoric disorder. Am. J. Obstet. Gynecol. 2010, 203, 181. [Google Scholar] [CrossRef] [PubMed]
  116. Metcalf, M.G.; Braiden, V.; Livesey, J.H. Symptom cyclicity in women with the premenstrual syndrome: An 8-year follow-up study. J. Psychosom. Res. 1992, 36, 237–241. [Google Scholar] [CrossRef] [PubMed]
  117. Metcalf, M.G.; Livesey, J.H.; Wells, J.E.; Braiden, V. Physical symptom cyclicity in women with and without the premenstrual syndrome. J. Psychosom. Res. 1990, 34, 203–213. [Google Scholar] [CrossRef]
  118. Nigam, S.; Benedetto, C.; Zonca, M.; Leo-Rossberg, I.; Lübbert, H.; Hammerstein, J. Increased concentrations of eicosanoids and platelet-activating factor in menstrual blood from women with primary dysmenorrhea. Eicosanoids 1991, 4, 137–141. [Google Scholar]
  119. Nillni, Y.I.; Berenz, E.C.; Pineles, S.L.; Coffey, S.F.; Zvolensky, M.J. Anxiety sensitivity as a moderator of the association between premenstrual symptoms and posttraumatic stress disorder symptom severity. Psychol. Trauma Theory Res. Pract. Policy 2014, 6, 167–175. [Google Scholar] [CrossRef] [Green Version]
  120. Olson, B.R.; Forman, M.R.; Lanza, E.; McAdam, P.A.; Beecher, G.; Kimzey, L.M.; Campbell, W.S.; Raymond, E.G.; Brentzel, S.L.; Güttsches-Ebeling, B. Relation between sodium balance and menstrual cycle symptoms in normal women. Ann. Intern. Med. 1996, 125, 564–567. [Google Scholar] [CrossRef]
  121. Oral, E.; Ozcan, H.; Kirkan, T.S.; Askin, S.; Gulec, M.; Aydin, N. Luteal serum BDNF and HSP70 levels in women with premenstrual dysphoric disorder. Eur. Arch. Psychiatry Clin. Neurosci. 2013, 263, 685–693. [Google Scholar] [CrossRef]
  122. Ozgocer, T.; Ucar, C.; Yildiz, S. Cortisol awakening response is blunted and pain perception is increased during menses in cyclic women. Psychoneuroendocrinology 2017, 77, 158–164. [Google Scholar] [CrossRef] [PubMed]
  123. Rasheed, P.; Al-Sowielem, L.S. Prevalence and predictors of premenstrual syndrome among college-aged women in Saudi Arabia. Ann. Saudi Med. 2003, 23, 381–387. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  124. Rossignol, A.M. Caffeine-containing beverages and premenstrual syndrome in young women. Am. J. Public Health 1985, 75, 1335–1337. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  125. Rossignol, A.M.; Bonnlander, H. Prevalence and severity of the premenstrual syndrome. Effects of foods and beverages that are sweet or high in sugar content. J. Reprod. Med. 1991, 36, 131–136. [Google Scholar]
  126. Sadler, C.; Smith, H.; Hammond, J.; Bayly, R.; Borland, S.; Panay, N.; Crook, D.; Inskip, H. Lifestyle factors, hormonal contraception, and premenstrual symptoms: The United Kingdom Southampton Women's Survey. J. Womens Health 2010, 19, 391–396. [Google Scholar] [CrossRef] [Green Version]
  127. Sahin, M.E.; Sahin, E.; Madendag, Y.; Madendag, I.C.; Tayyar, A.T.; Özdemir, F.; Acmaz, G.; Muderris, I.I. The effect of anterior uterocervical angle on primary dysmenorrhea and disease severity. Pain Res. Manag. 2018, 2018, 9819402. [Google Scholar] [CrossRef]
  128. Sen, E.; Ozdemir, O.; Ozdemir, S.; Atalay, C.R. The relationship between serum ischemia-modified albumin levels and uterine artery doppler parameters in patients with primary dysmenorrhea. Rev. Bras. Ginecol. Obs. 2020, 42, 630–633. [Google Scholar] [CrossRef]
  129. Shrestha, D.B.; Shrestha, S.; Dangol, D.; Aryal, B.B.; Shrestha, S.; Sapkota, B.; Rai, S. Premenstrual syndrome in students of a teaching hospital. J. Nepal Health Res. Counc. 2019, 17, 253–257. [Google Scholar] [CrossRef]
  130. Simpson, L.O.; Shand, B.I.; Nyhof, R.B. Factors influencing the cyclical symptoms relating to the menstrual cycle. N. Zealand Med. J. 1988, 101, 225–228. [Google Scholar]
  131. Takeda, T.; Shiina, M. Effect of an educational program on adolescent premenstrual syndrome: Lessons from the Great East Japan Earthquake. Adolesc. Health Med. 2018, 9, 95–101. [Google Scholar] [CrossRef] [Green Version]
  132. Takeda, T.; Tadakawa, M.; Koga, S.; Nagase, S.; Yaegashi, N. Relationship between dysmenorrhea and posttraumatic stress disorder in Japanese high school students 9 months after the Great East Japan Earthquake. J. Pediatr. Adolesc. Gynecol. 2013, 26, 355–357. [Google Scholar] [CrossRef] [PubMed]
  133. Telek, T.; Gonda, X.; Lazary, J.; Benko, A.; Pap, D.; Vargha, A.; Bagdy, G. The possible protective role of personality dimensions against premenstrual syndrome. Psychiatry Res. 2010, 179, 81–85. [Google Scholar] [CrossRef] [PubMed]
  134. Thompson, M.L.; Gick, M.L. Medical care-seeking for menstrual symptoms. J. Psychosom. Res. 2000, 49, 137–140. [Google Scholar] [CrossRef] [PubMed]
  135. Warren, C.J.; Baker, S. Coping resources of women with premenstrual syndrome. Arch. Psychiatr. Nurs. 1992, 6, 48–53. [Google Scholar] [CrossRef] [PubMed]
  136. Wu, M.; Liang, Y.; Wang, Q.; Zhao, Y.; Zhou, R. Emotion dysregulation of women with premenstrual syndrome. Sci. Rep. 2016, 6, 38501. [Google Scholar] [CrossRef] [Green Version]
  137. Yen, J.Y.; Lin, H.C.; Lin, P.C.; Liu, T.L.; Long, C.Y.; Ko, C.H. Early- and late-luteal-phase estrogen and progesterone levels of women with premenstrual dysphoric disorder. Int. J. Environ. Res. Public Health 2019, 16, 4352. [Google Scholar] [CrossRef] [Green Version]
  138. Lindh, I.; Ellström, A.A.; Milsom, I. The effect of combined oral contraceptives and age on dysmenorrhoea: An epidemiological study. Hum. Reprod. 2012, 27, 676–682. [Google Scholar] [CrossRef] [Green Version]
  139. Warren, M.P.; Goodman, L.R. Exercise-induced endocrine pathologies. J. Endocrinol. Investig. 2003, 26, 873–878. [Google Scholar] [CrossRef]
  140. Manore, M.M.; Kam, L.C.; Loucks, A.B. The female athlete triad: Components, nutrition issues, and health consequences. J. Sport. Sci. 2007, 25, S61–S71. [Google Scholar] [CrossRef]
  141. Ju, H.; Jones, M.; Mishra, G.D. A U-shaped relationship between body mass index and dysmenorrhea: A longitudinal study. PLoS ONE 2015, 10, e0134187. [Google Scholar] [CrossRef]
  142. Pasquali, R.; Pelusi, C.; Genghini, S.; Cacciari, M.; Gambineri, A. Obesity and reproductive disorders in women. Hum. Reprod. Update 2003, 9, 359–372. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  143. Su, S.; Duan, J.; Wang, P.; Liu, P.; Guo, J.; Shang, E.; Qian, D.; Tang, Y.; Tang, Z. Metabolomic study of biochemical changes in the plasma and urine of primary dysmenorrhea patients using UPLC-MS coupled with a pattern recognition approach. J. Proteome Res. 2013, 12, 852–865. [Google Scholar] [CrossRef] [PubMed]
  144. Nohara, M.; Momoeda, M.; Kubota, T.; Nakabayashi, M. Menstrual cycle and menstrual pain problems and related risk factors among Japanese female workers. Ind. Health 2011, 49, 228–234. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  145. Sooki, Z.; Shariati, M.; Chaman, R.; Khosravi, A.; Effatpanah, M.; Keramat, A. The Role of mother in informing girls about puberty: A meta-analysis study. Nurs. Midwifery Stud. 2016, 5, e30360. [Google Scholar] [CrossRef] [Green Version]
  146. Chrousos, G.P.; Torpy, D.J.; Gold, P.W. Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: Clinical implications. Ann. Intern. Med. 1998, 129, 229–240. [Google Scholar] [CrossRef] [Green Version]
  147. Crowley, S.J.; Acebo, C.; Carskadon, M.A. Sleep, circadian rhythms, and delayed phase in adolescence. Sleep Med. 2007, 8, 602–612. [Google Scholar] [CrossRef]
  148. Rojansky, N.; Brzezinski, A.; Schenker, J.G. Seasonality in human reproduction: An update. Hum. Reprod. 1992, 7, 735–745. [Google Scholar] [CrossRef]
  149. Esquifino, A.I.; Villanúa, M.A.; Agrasal, C. Effect of neonatal melatonin administration on sexual development in the rat. J. Steroid Biochem. 1987, 27, 1089–1093. [Google Scholar] [CrossRef] [PubMed]
  150. Villanúa, M.A.; Agrasal, C.; Esquifino, A.I. Neonatal melatonin administration advances rat vaginal opening and disrupts estrous cyclicity and estrogen-dependent regulatory mechanisms of luteinizing hormone and prolactin. J. Pineal Res. 1989, 7, 165–174. [Google Scholar]
  151. Dehnavi, Z.M.; Jafarnejad, F.; Kamali, Z. The Effect of aerobic exercise on primary dysmenorrhea: A clinical trial study. J. Educ. Health Promot. 2018, 7, 3. [Google Scholar] [CrossRef]
  152. Pascoe, M.C.; Thompson, D.R.; Ski, C.F. Yoga, mindfulness-based stress reduction and stress-related physiological measures: A meta-analysis. Psychoneuroendocrinology 2017, 86, 152–168. [Google Scholar] [CrossRef] [PubMed]
  153. Momma, R.; Nakata, Y.; Sawai, A.; Takeda, M.; Natsui, H.; Mukai, N.; Watanabe, K. Comparisons of the prevalence, severity, and risk factors of dysmenorrhea between Japanese female athletes and non-athletes in universities. Int. J. Environ. Res. Public Health 2021, 19, 52. [Google Scholar] [CrossRef] [PubMed]
  154. Buscicchio, G.; Piemontese, M.; Gentilucci, L.; Ferretti, F.; Tranquilli, A.L. The effects of maternal caffeine and chocolate intake on fetal heart rate. J. Matern.-Fetal Neonatal Med. 2012, 25, 528–530. [Google Scholar] [CrossRef] [PubMed]
  155. Hashim, R.T.; Alkhalifah, S.S.; Alsalman, A.A.; Alfaris, D.M.; Alhussaini, M.A.; Qasim, R.S.; Shaik, S.A. Prevalence of primary dysmenorrhea and its effect on the quality of life amongst female medical students at King Saud University, Riyadh, Saudi Arabia. A cross-sectional study. Saudi Med. J. 2020, 41, 283–289. [Google Scholar] [CrossRef]
  156. Echeverri, D.; Montes, F.R.; Cabrera, M.; Galán, A.; Prieto, A. Caffeine's vascular mechanisms of action. Int. J. Vasc. Med. 2010, 2010, 834060. [Google Scholar] [CrossRef] [Green Version]
  157. Sawant, O.B.; Ramadoss, J.; Hankins, G.D.; Wu, G.; Washburn, S.E. Effects of L-glutamine supplementation on maternal and fetal hemodynamics in gestating ewes exposed to alcohol. Amino Acids 2014, 46, 1981–1996. [Google Scholar] [CrossRef] [Green Version]
  158. Nagata, C.; Hirokawa, K.; Shimizu, N.; Shimizu, H. Associations of menstrual pain with intakes of soy, fat and dietary fiber in Japanese women. Eur. J. Clin. Nutr. 2005, 59, 88–92. [Google Scholar] [CrossRef] [Green Version]
  159. Fujiwara, T.; Nakata, R. Skipping breakfast is associated with reproductive dysfunction in post-adolescent female college students. Appetite 2010, 55, 714–717. [Google Scholar] [CrossRef] [PubMed]
  160. Kaimura, M.; Ueda, K. Menstruation in young women: Associated symptoms, related factors, and effects on QOL. J. Jpn. Soc. Psychosom. Obstet. Gynecol. 2013, 18, 412–421. (In Japanese) [Google Scholar]
Ijerph 20 00569 g001 550
Figure 1. Flow diagram of literature search.
Figure 1. Flow diagram of literature search.
Ijerph 20 00569 g001
Ijerph 20 00569 g002 550
Figure 2. Forest plot showing a meta-analysis of studies comparing the number of women aged ≥20 years with and without PD [5,6]. The analysis was performed using a random-effects model. PD, primary dysmenorrhea. The black diamond and its extremities indicate the pooled risk ratio center and a 95% confidential interval.
Figure 2. Forest plot showing a meta-analysis of studies comparing the number of women aged ≥20 years with and without PD [5,6]. The analysis was performed using a random-effects model. PD, primary dysmenorrhea. The black diamond and its extremities indicate the pooled risk ratio center and a 95% confidential interval.
Ijerph 20 00569 g002
Ijerph 20 00569 g003 550
Figure 3. Forest plot showing a meta-analysis of studies comparing the number of women with BMI < 18.5 kg/m2 with and without PD [5,6,38,68]. The analysis was performed using a random-effects model. PD, primary dysmenorrhea. The black diamond and its extremities indicate the pooled risk ratio center and a 95% confidential interval.
Figure 3. Forest plot showing a meta-analysis of studies comparing the number of women with BMI < 18.5 kg/m2 with and without PD [5,6,38,68]. The analysis was performed using a random-effects model. PD, primary dysmenorrhea. The black diamond and its extremities indicate the pooled risk ratio center and a 95% confidential interval.
Ijerph 20 00569 g003
Ijerph 20 00569 g004 550
Figure 4. Forest plot showing a meta-analysis of studies comparing menstrual days with and without PD [9,10,28,38,83]. The analysis was performed using a random-effects model. PD, primary dysmenorrhea. The black diamond and its extremities indicate the pooled risk ratio center and a 95% confidential interval.
Figure 4. Forest plot showing a meta-analysis of studies comparing menstrual days with and without PD [9,10,28,38,83]. The analysis was performed using a random-effects model. PD, primary dysmenorrhea. The black diamond and its extremities indicate the pooled risk ratio center and a 95% confidential interval.
Ijerph 20 00569 g004
Ijerph 20 00569 g005 550
Figure 5. Forest plot showing a meta-analysis of studies comparing the number of women who have irregular menstrual cycles with and without PD [6,28,83]. The analysis was performed using a random-effects model. PD, primary dysmenorrhea. The black diamond and its extremities indicate the pooled risk ratio center and a 95% confidential interval.
Figure 5. Forest plot showing a meta-analysis of studies comparing the number of women who have irregular menstrual cycles with and without PD [6,28,83]. The analysis was performed using a random-effects model. PD, primary dysmenorrhea. The black diamond and its extremities indicate the pooled risk ratio center and a 95% confidential interval.
Ijerph 20 00569 g005
Ijerph 20 00569 g006 550
Figure 6. Forest plot showing a meta-analysis of studies comparing the number of women who have a family history of PD with and without PD [5,28,34,66]. The analysis was performed using a random-effects model. PD, primary dysmenorrhea. The black diamond and its extremities indicate the pooled risk ratio center and a 95% confidential interval.
Figure 6. Forest plot showing a meta-analysis of studies comparing the number of women who have a family history of PD with and without PD [5,28,34,66]. The analysis was performed using a random-effects model. PD, primary dysmenorrhea. The black diamond and its extremities indicate the pooled risk ratio center and a 95% confidential interval.
Ijerph 20 00569 g006
Ijerph 20 00569 g007 550
Figure 7. Forest plot showing a meta-analysis of studies comparing the number of women with and without PD who have higher stress levels [5,83]. The analysis was performed using a random-effects model. PD, primary dysmenorrhea. The black diamond and its extremities indicate the pooled risk ratio center and a 95% confidential interval.
Figure 7. Forest plot showing a meta-analysis of studies comparing the number of women with and without PD who have higher stress levels [5,83]. The analysis was performed using a random-effects model. PD, primary dysmenorrhea. The black diamond and its extremities indicate the pooled risk ratio center and a 95% confidential interval.
Ijerph 20 00569 g007
Ijerph 20 00569 g008 550
Figure 8. Forest plot showing a meta-analysis of studies comparing the number of women with and without PD sleeping < 7 h [6,20]. The analysis was performed using a random-effects model. PD, primary dysmenorrhea. The black diamond and its extremities indicate the pooled risk ratio center and a 95% confidential interval.
Figure 8. Forest plot showing a meta-analysis of studies comparing the number of women with and without PD sleeping < 7 h [6,20]. The analysis was performed using a random-effects model. PD, primary dysmenorrhea. The black diamond and its extremities indicate the pooled risk ratio center and a 95% confidential interval.
Ijerph 20 00569 g008
Ijerph 20 00569 g009 550
Figure 9. Forest plot showing meta-analysis of studies comparing the number of women with and without PD who go to bed at 23:01 or later [6,20]. The analysis was performed using a random-effects model. PD, primary dysmenorrhea. The black diamond and its extremities indicate the pooled risk ratio center and a 95% confidential interval.
Figure 9. Forest plot showing meta-analysis of studies comparing the number of women with and without PD who go to bed at 23:01 or later [6,20]. The analysis was performed using a random-effects model. PD, primary dysmenorrhea. The black diamond and its extremities indicate the pooled risk ratio center and a 95% confidential interval.
Ijerph 20 00569 g009
Ijerph 20 00569 g010 550
Figure 10. Forest plot showing a meta-analysis of studies comparing the number of women with BMI < 18.5 kg/m2 by the severity of PD (severe vs. moderate) [58,68]. The analysis was performed using a random-effects model. PD, primary dysmenorrhea. The black diamond and its extremities indicate the pooled risk ratio center and a 95% confidential interval.
Figure 10. Forest plot showing a meta-analysis of studies comparing the number of women with BMI < 18.5 kg/m2 by the severity of PD (severe vs. moderate) [58,68]. The analysis was performed using a random-effects model. PD, primary dysmenorrhea. The black diamond and its extremities indicate the pooled risk ratio center and a 95% confidential interval.
Ijerph 20 00569 g010
Ijerph 20 00569 g011 550
Figure 11. Forest plot showing a meta-analysis of studies comparing the number of women with a smoking habit by the severity of PD (severe vs moderate) [34,66]. The analysis was performed using a random-effects model. PD, primary dysmenorrhea. The black diamond and its extremities indicate the pooled risk ratio center and a 95% confidential interval.
Figure 11. Forest plot showing a meta-analysis of studies comparing the number of women with a smoking habit by the severity of PD (severe vs moderate) [34,66]. The analysis was performed using a random-effects model. PD, primary dysmenorrhea. The black diamond and its extremities indicate the pooled risk ratio center and a 95% confidential interval.
Ijerph 20 00569 g011
Ijerph 20 00569 g012 550
Figure 12. Forest plot showing a meta-analysis of studies comparing the number of women with BMI < 18.5 kg/m2 by the severity of PD (severe vs. mild) [58,68]. The analysis was performed using a random-effects model. PD, primary dysmenorrhea. The black diamond and its extremities indicate the pooled risk ratio center and a 95% confidential interval.
Figure 12. Forest plot showing a meta-analysis of studies comparing the number of women with BMI < 18.5 kg/m2 by the severity of PD (severe vs. mild) [58,68]. The analysis was performed using a random-effects model. PD, primary dysmenorrhea. The black diamond and its extremities indicate the pooled risk ratio center and a 95% confidential interval.
Ijerph 20 00569 g012
Ijerph 20 00569 g013 550
Figure 13. Forest plot showing a meta-analysis of studies comparing the number of women with and without PMS with a smoking habit [32,43,70]. The analysis was performed using a random-effects model. PMS, premenstrual syndrome. The black diamond and its extremities indicate the pooled risk ratio center and a 95% confidential interval.
Figure 13. Forest plot showing a meta-analysis of studies comparing the number of women with and without PMS with a smoking habit [32,43,70]. The analysis was performed using a random-effects model. PMS, premenstrual syndrome. The black diamond and its extremities indicate the pooled risk ratio center and a 95% confidential interval.
Ijerph 20 00569 g013
Table
Table 1. Database search strategies.
Table 1. Database search strategies.
DatabasesSearch Strategies (January 2021)
PubMed((“premenstrual syndrome” [All Fields]) OR (“premenstrual dysphoric disorder” [All Fields]) OR (“functional dysmenorrhea” [All Fields]) OR (“primary dysmenorrhea” [All Fields]) OR (“menstrual pain” [All Fields]) OR (“menstrual symptoms” [All Fields]))
AND ((“risk factors” [All Fields]) OR (“severity” [All Fields]) OR (“exacerbation” [All Fields]) OR (“limitation” [All Fields]) OR (“activity of daily life” [All Fields]) OR (“limiting factors” [All Fields]))
Ichushi(“premenstrual syndrome” OR “premenstrual dysphoric disorder” OR “functional dysmenorrhea” OR “primary dysmenorrhea” OR “menstrual pain” OR “menstrual symptoms”)
AND (“risk factors” OR “severity” OR “exacerbation” OR “limitation” OR “activity of daily life” OR “limiting factors”)
Table
Table 2. Onset of primary dysmenorrhea (%).
Table 2. Onset of primary dysmenorrhea (%).
First Author (Year)Before MenstruationFirst Day of Menstruationon or after the Second Day of Menstruation
Hu et al. (2020) [6]24.560.814.7
Balbi et al. (2000) [13]70.0N/A
Chen et al. (2005) [45]N/A49.8N/A
Kural et al. (2015) [59]23.561.514.2
Monday et al. (2019) [64]N/A31.6N/A
Orhan et al. (2018) [66]35.065.0N/A
Rafique et al. (2018) [68]44.540.115.5
N/A, not applicable.
Table
Table 3. Duration of primary dysmenorrhea and premenstrual syndrome.
Table 3. Duration of primary dysmenorrhea and premenstrual syndrome.
First Author (Year)Mean ± SD1 Day2 Days3 Days4 DaysOver 5 Days
Hu et al. (2020) [6]N/AN/A95.34.7N/AN/A
Balbi et al. (2000) [13]N/AN/AMost
frequent		N/AN/AN/A
Liu et al. (2017) [23]1.9 ± 0.38
(days)		N/AN/AN/AN/AN/A
Carman et al. (2018) [44]4.37 ± 5.55 a
(hours)		N/AN/AN/AN/AN/A
Harlow et al. (1996) [53]1.7 b
(days)		N/AN/AN/AN/AN/A
Kural et al. (2015) [59]N/A37.039.815.45.42.3
Orhan et al. (2018) [66]2.0 [1.0–3.0] c
(days)		N/AN/AN/AN/AN/A
Rafique et al. (2018) [68]N/A25.255.5N/AN/AN/A
N/A, not applicable. a Data are presented as mean durations of menstruation-related headache. b SD was not shown. c Data are presented as medians [25th/75th percentile].
Table
Table 4. Effects of primary dysmenorrhea (%).
Table 4. Effects of primary dysmenorrhea (%).
First Author (Year)Daily LifeWork or SchoolSports
Activities		Social
Activities		Less
Concentration		Felt More RestedAvoidance of Responsibility
Chen et al. (2005) [45]92.425.3N/AN/AN/AN/AN/A
Orhan et al. (2018) [66]N/A4.44.54.5N/AN/AN/A
Rafique et al. (2018) [68]54.5N/A25.2N/AN/AN/AN/A
Tangchai et al. (2004) [75]N/A21.137.318.263.6N/AN/A
Zukri et al. (2009) [83]88.231.1N/A81.2N/A99.992.1
N/A, not applicable.
Table
Table 5. Methods of coping with primary dysmenorrhea (%).
Table 5. Methods of coping with primary dysmenorrhea (%).
First Author (year)AnalgesicsWarmingRestExerciseMedical TreatmentHerbal
Medicine		Meditating
Kordi et al. (2013)
[21]		67.0N/AN/AN/AN/AN/AN/A
Chen et al. (2005)
[45]		39.9N/AN/AN/AN/AN/AN/A
Rafique et al. (2018) [68]63.718.3N/AN/AN/AN/AN/A
Tangchai et al. (2004) [75]32.534.092.06.87.112.74.5
N/A, not applicable.
Table
Table 6. Effects of premenstrual syndrome (%).
Table 6. Effects of premenstrual syndrome (%).
First Author (Year)Daily LifeWork or SchoolRelationships
Hashim et al. (2019) [54]71.344.748.0
Tadakawa et al. (2016) [73]N/A42.9N/A
N/A, not applicable.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Mitsuhashi, R.; Sawai, A.; Kiyohara, K.; Shiraki, H.; Nakata, Y. Factors Associated with the Prevalence and Severity of Menstrual-Related Symptoms: A Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public Health 2023, 20, 569. https://doi.org/10.3390/ijerph20010569

AMA Style

Mitsuhashi R, Sawai A, Kiyohara K, Shiraki H, Nakata Y. Factors Associated with the Prevalence and Severity of Menstrual-Related Symptoms: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health. 2023; 20(1):569. https://doi.org/10.3390/ijerph20010569

Chicago/Turabian Style

Mitsuhashi, Risa, Akemi Sawai, Kosuke Kiyohara, Hitoshi Shiraki, and Yoshio Nakata. 2023. "Factors Associated with the Prevalence and Severity of Menstrual-Related Symptoms: A Systematic Review and Meta-Analysis" International Journal of Environmental Research and Public Health 20, no. 1: 569. https://doi.org/10.3390/ijerph20010569

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop